HBV-specific CD8 cells show altered MHC/peptide binding in the presence of high levels of circulating viral antigen.

HBV-specific CD8 cells show altered MHC/peptide binding in the presence of high levels of circulating viral antigen.

Bibliographic Details
Main Authors:	Reignat, S, Webster, G, Brown, D, Ogg, G, Williams, R, Dusheiko, G, Maini, M, Bertoletti, A
Format:	Journal article
Published:	2001

Similar Items

Deletion and tolerance of HBV-specific CD8 T cells during chronic HBV infection
by: Webster, G, et al.
Published: (2003)

Skewed repertoire of HBV-specific CD8 T cell response in chronic HBV infection
by: Webster, G, et al.
Published: (2003)

Skewed repertoire of HBV-specific CD8 T cell response in chronic HBV infection.
by: Webster, G, et al.
Published: (2002)

Kinetics of the HBV-specific CTL response
by: Maini, M, et al.
Published: (1999)

Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection.
by: Reignat, S, et al.
Published: (2002)

Hepatocyte lysis by HBV-specific CD8 cells may not be the principal mechanism of viral control in acute hepatitis B.
by: Webster, G, et al.
Published: (1999)

Dynamics of HBV-specific CD4 and CD8 response during early phase of acute hepatitis B
by: Webster, G, et al.
Published: (2000)

Distinct functional patterns of HBV-specific CD8+cell response in hepatitis B virus infection
by: Webster, G, et al.
Published: (2001)

Chemokine receptor expression and cytokine production of HBV-specific CD8 cells
by: Larrubia, JR, et al.
Published: (2000)

T cell receptor usage of virus-specific CD8 cells and recognition of viral mutations during acute and persistent hepatitis B virus infection.
by: Maini, M, et al.
Published: (2000)

Direct visualisation of hepatitis B virus (HBV)-specific cytotoxic T cells with an human leucocyte antigen (HLA) class I peptide tetrameric complex allows a new insight into their actual frequency.
by: Maini, M, et al.
Published: (1998)

Acute flares in chronic hepatitis B are not coupled with increases in virus-specific T cell response
by: Webster, G, et al.
Published: (2003)

Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer.
by: Spies, T, et al.
Published: (1992)

MHC class I antigen processing regulated by cytosolic proteolysis-short cuts that alter peptide generation.
by: Kessler, B, et al.
Published: (2002)

Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy.
by: Webster, G, et al.
Published: (2004)

MHC-peptide tetramers for the analysis of antigen-specific T cells.
by: Sims, S, et al.
Published: (2010)

The design and development of a multi-hbv antigen encoded in chimpanzee adenoviral and modified vaccinia ankara viral vectors; a novel therapeutic vaccine strategy against HBV
by: Chinnakannan, SK, et al.
Published: (2020)

Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8+ T Cell–Effector Responses
by: Devlin, Christine A., et al.
Published: (2020)

KIR content genotypes associate with carriage of hepatitis B surface antigen, e antigen and HBV viral load in Gambians
by: Yindom, L, et al.
Published: (2017)

Role of circulating IL-10 in acute viral hepatitis
by: Nebbia, G, et al.
Published: (2006)

Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms.
by: Webster, G, et al.
Published: (2000)

Silencing of the early innate immune response in patients with acute hbv infection
by: Dunn, C, et al.
Published: (2008)

Dependence of T cell antigen recognition on T cell receptor-peptide MHC confinement time.
by: Aleksic, M, et al.
Published: (2010)

A novel chimpanzee adenoviral vectored HBV vaccine, encoding multiple HBV antigens with a shark invariant chain adjuvant, for use in HBV immunotherapy
by: Chinnakannan, S, et al.
Published: (2018)

Quantum dot/peptide-MHC biosensors reveal strong CD8-dependent cooperation between self and viral antigens that augment the T cell response.
by: Anikeeva, N, et al.
Published: (2006)

Coreceptor affinity for MHC defines peptide specificity requirements for TCR interaction with coagonist peptide-MHC
by: Hoerter, John A. H., et al.
Published: (2014)

Characterisation of HBV and SARS-CoV-2 spike specific T cells and their association with viral control
by: Liu, G
Published: (2023)

Structural and biophysical studies of HIV Rev and HBV e-antigen
by: DiMattia, M
Published: (2012)

Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent.
by: Whelan, J, et al.
Published: (1999)

Levels of circulating angiogenic cells are not altered in women with endometriosis.
by: Webster, K, et al.
Published: (2013)

Oligomeric MHC molecules and their homologues: state of the art.
by: Dunbar, P, et al.
Published: (2002)

Viral infection causes a shift in the self peptide repertoire presented by human MHC class I molecules
by: Spencer, CT, et al.
Published: (2015)

Folding of an MHC class II-restricted tumor antigen controls its antigenicity via MHC-guided processing.
by: Mimura, Y, et al.
Published: (2007)

The role of virus-specific CD8+cells in liver damage and viral control during persistent hepatitis B virus infection
by: Maini, M, et al.
Published: (2000)

Shared immunotherapeutic approaches in HIV and HBV: Combine and conquer
by: Maini, M, et al.
Published: (2020)

Induction of dominant transplantation tolerance by an altered peptide ligand of the male antigen Dby
by: Chen, T, et al.
Published: (2004)

Induction of dominant transplantation tolerance by an altered peptide ligand of the male antigen Dby.
by: Chen, T, et al.
Published: (2004)

Viral escape and T cell exhaustion in hepatitis C virus infection analysed using Class I peptide tetramers.
by: Kantzanou, M, et al.
Published: (2003)

Evolutionary approaches for predicting MHC peptide binding
by: Rajapakse, Menaka Priyadharasani
Published: (2009)

MECHANISM OF MHC-MEDIATED ANTIGEN RECOGNITION BY T-CELLS
by: Bowness, P, et al.
Published: (1993)